Michael R. McAlevey - Jan 28, 2022 Form 4 Insider Report for HCA Healthcare, Inc. (HCA)

Role
SVP & Chief Legal Officer
Signature
/s/ Kevin A. Ball, Attorney-in-Fact
Stock symbol
HCA
Transactions as of
Jan 28, 2022
Transactions value $
$0
Form type
4
Date filed
2/1/2022, 06:29 PM
Previous filing
Feb 1, 2022
Next filing
May 3, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HCA Stock Appreciation Right Award $0 +13.9K $0.00 13.9K Jan 28, 2022 Common Stock 13.9K $236.61 Direct F1
transaction HCA Stock Appreciation Right Award $0 +13.2K $0.00 13.2K Jan 28, 2022 Common Stock 13.2K $236.61 Direct F2
transaction HCA Restricted Stock Units Award $0 +3.88K $0.00 3.88K Jan 28, 2022 Common Stock 3.88K Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock appreciation rights vest in four equal annual installments beginning on January 28, 2023.
F2 The stock appreciation rights vest in two equal annual installments beginning on January 28, 2023.
F3 Each restricted stock unit represents a contingent right to receive one share of HCA Healthcare, Inc. common stock.
F4 The restricted stock units vest in two equal annual installments beginning on January 28, 2023.